Takeda Pharmaceutical Company Limited Interest Income For Financial Assets Measured At Amortised Cost
Takeda Pharmaceutical Company Limited (TKPHF) reported Interest Income For Financial Assets Measured At Amortised Cost of JPY 16.58 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Other Income
ifrs-full:InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost · last filed 2025-06-25
| Period end | Interest Income For Financial Assets Measured At Amortised Cost 12 month |
|---|---|
| 2025-03-31 | 16.58B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 8.85B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 4.19B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 3.88B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.12B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 10.76B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 6.17B JPY 20-F · filed 2021-06-29 |